The initial B-cell repertoire is generated by combinatorial immunoglobulin V(D)J gene segment rearrangements that occur in a preferential sequence. Because cellular proliferation occurs during the course of these rearrangement events, it has been proposed that intraclonal diversification occurs during this phase of B-cell development. An opportunity to examine this hypothesis directly was provided by the identification of a human acute lym- 
Introduction
B-cell development normally begins within specialized microenvironments in the hematopoietic fetal liver and bone marrow. Therein precursor cells undergo proliferation during the course of a series of differentiation events featuring the ordered rearrangement of variable (V), diversity (D), and joining (J) gene segments to generate a diverse antibody repertoire. 1 The D3J H gene rearrangements in progenitor B (pro-B) cells are followed by V3DJ H rearrangements that allow precursor B (pre-B) cells to produce heavy chains (HCs). 2, 3 The HCs associate with the surrogate light chains (SLCs), composed of VpreB and 5/14.1 proteins, and Ig␣/␤ heterodimers to form the pre-B cell receptor (pre-BCR; Karasuyama et al 4 and Burrows et al 5 and references therein). Signaling initiated via this receptor complex is essential for pre-B cell survival, proliferation, and transient down-regulation of recombination-activating genes (Rag1/2) to terminate V(D)J rearrangements in the immunoglobulin (Ig) HC locus. 6, 7 The subsequent extinction of SLC gene expression is temporally related to an exit from the cell cycle, Rag1/2 up-regulation, and Ig light chain (LC) V-J gene rearrangement. [8] [9] [10] [11] Immature IgM ϩ B cells generated by productive V L -J L rearrangements may then undergo positive or negative selection by encounter with self-antigens. 12, 13 B-cell clonality is usually defined operationally by the shared expression of a unique BCR specificity, although intraclonal antigen receptor diversity may be generated by several mechanisms. Antibody diversity can be generated by receptor editing, a process by which the specificity of an autoreactive BCR is changed thorough a secondary V L -J L rearrangement at an immature B-cell stage. 14, 15 Additional intraclonal BCR diversification can be generated by point mutations in the variable region during antigen (Ag)-driven clonal expansion in germinal centers. 1, 16, 17 B-cell malignancies, including follicular B-cell lymphoma, chronic lymphocytic leukemia, and Hodgkin disease, may exhibit this type of clonal diversification as a manifestation of their germinal center (GC) origin. 18 It has been proposed that intraclonal diversity may also be generated as a consequence of the cellular proliferation that accompanies the normal stepwise V(D)J rearrangement events in pro-B and pre-B cells. 19 According to this hypothesis, a pro-B cell undergoing the initial DJ H rearrangement can give rise to daughter cells that select different V H genes for subsequent V-DJ H rearrangement. In turn, the pre-B cell progeny would have the opportunity to select different V L and J L gene segments for VJ L pairing, thereby providing additional intraclonal BCR diversity. Because a clonal model of early B-lineage differentiation would allow testing of this hypothesis, we sought a stable cell line that recapitulates this developmental process. Here, we report the characterization of a human acute lymphoblastic leukemic (ALL) cell line, EU12, that undergoes continual B-lineage differentiation from the pro-B to the pre-B and B-cell stages. Analysis of this clonal model of human B-lineage differentiation validates the principle of intraclonal V(D)J recombinatorial diversification during B-cell genesis.
Materials and methods

Cells and antibodies
The EU12 cell line was established from bone marrow cells obtained from a child with relapsed B-cell precursor ALL. [20] [21] [22] The EU12 cell line was found to be negative for Epstein-Barr virus-associated nuclear antigen (EBNA) and to represent the leukemic clone by immunophenotypic analysis. The Nalm16 pro-B, OB5 pre-B, and EU12 ALL cell lines were cultured in Iscove medium supplemented with 100 U/mL penicillin, 100 g/mL streptomycin, 10% heat-inactivated fetal calf serum (FCS), and 2 mM L-glutamine. (Life Technologies, Grand Island, NY). Immunofluorescence assays used the following monoclonal antibodies (mAbs): fluorescein isothiocyanate (FITC)-conjugated CD2, CD3, CD5, CD10, CD11a, and CD34 (Becton Dickinson, Mountain View, CA); phycoerythrin (PE)-conjugated CD19, CD20, CD21, CD23, and HLA-DR (Becton Dickinson); FITC-conjugated CD45RA and antihuman LC; PE-conjugated CD32, CD33, CD69, and VpreB8 (Pharmingen, San Diego, CA); and the CY5-labeled VpreB8 mAb as described previously. 23 Polyclonal antibodies included FITC-labeled anti-terminal deoxynucleotidyl transferase (TdT; Supertechs, Bethesda, MD), FITC-labeled goat anti-HC, biotin-conjugated goat anti-HC, and PE-labeled goat anti-IgD. Allophycocyanin (APC)-conjugated streptavidin (Southern Biotechnology, Birmingham, AL) was used as a second-step reagent for the biotin-labeled antibodies.
Immunofluorescence analysis and cell sorting
Viable cells were incubated with conjugated mAbs for immunofluorescence analysis and for fluorescence-activated cell sorting (FACS). Subpopulations of the EU12 cells were purified by 2 rounds of sorting using FACSTAR (Becton Dickinson) and MoFlow (Cytomation, Fort Collin, CO) instruments. For intracellular staining, the purified subpopulations of cells were fixed in 0.05% paraformaldehyde solution at 4°C for 1 hour, permeabilized with 0.2% Tween-20 in phosphate-buffered saline at room temperature for 20 minutes, and blocked with mouse serum for 10 minutes before incubation with fluorochrome-conjugated antibodies.
RT-PCR assays
Twice-sorted subpopulations of EU12 cells were lysed in TRIzol reagent (Gibco, Grand Island, NY), and total cellular RNA prepared following procedures recommended by the manufacturer. The synthesis of first-strand cDNA was performed as previously described. 23 For each cDNA preparation, a control synthesis reaction was performed without reverse transcriptase (RT) to test for genomic DNA (gDNA) contamination. The protocols for polymerase chain reaction (PCR) included denaturing at 94°C for 3 minutes amplification by 30 cycles of 94°C for 1 minute, annealing for 30 seconds at 60°C for interleukin 7 receptor (IL-7R) and mb-1; 65°C for C; and 72°C for Bcl-2; and extension at 72°C for 5 minutes. The primers for PCR amplification were IL-7R, 5Ј-GTCGCTCTGTTGGTCATCTTG-3Ј and 5Ј-TTTTG TCTTCTCTGTGCTGTG-3Ј; mb-1, 5Ј-GCTCCCCTAGAG-GCAGTTAAGG GC-3Ј and 5Ј-AGGGTAACCTCACTGTTAGGCCAG-GC-3Ј; C, 5Ј-TGGCTGCACCATCTGTC TTCA-3Ј and 5Ј-TTGAAGCTC-TTTGTGACGGGC-3Ј; Bcl-2, 5Ј-TGCACCTGACG CCCTTCAC-3Ј and 5Ј-AGACAGCCAGGAGAAATCAAACAG-3Ј. The protocols and primers used for PCR amplification of Rag1, Rag2, TdT, B29, C, and ␤-actin have been described. 11 
DNA blotting
gDNA samples from sorted EU12 subpopulations and placenta (germline configuration control) were subjected to restriction enzyme digestion, electrophoresis, transfer, and hybridization with 32 P-labeled DNA probes for analysis of Ig HC and LC gene configuration as described. 24 DNA probes, including a 3.6 kilobase (kb) BglII J H probe, a HindIII J probe, and an EcoRI C probe, were used as described. 24 Genomic PCR assay gDNA samples (0.5 g) from EU12 subpopulations and the control HepG2 cells were used as templates. The protocol for PCR amplification of IgH gene segments involved denaturing at 95°C for 5 minutes, amplifying by 36 cycles of 95°C for 1 minute, annealing at 65°C for 30 seconds and at 72°C for 30 seconds, and extending at 72°C for 5 minutes. The primers for amplification, DXPЈ1, 5Ј-ATTACTATGGTTCGGGGAGTT-3Ј; DXPЈ1ext, 5Ј-GGTGAGGTCTGTGTCACT-3Ј; J H 5, 5Ј-GTCGAACCAGTTGTCA-CATTG TG-3Ј; J H 6, 5Ј-ACCTGAGGAGACGGTGACC-3Ј, and Pan-V H FR1, and PanV H FR3 were as described. 25 The PCR products were separated by electrophoresis, transferred to a Nytran membrane (Schleicher and Schuell, Keene, NH). After standard prehybridization, the blots were hybridized at 42°C with oligonucleotide DXPЈ1 or J H 5 probes labeled with digoxigenin (DIG) using the DIG oligonucleotide 3Ј-end labeling kit (Boehringer Mannheim, Germany) according to the manufacturer's instructions. After washing at 42°C, hybridization signals were revealed using the DIG luminescence detection kit for nucleic acids (Boehringer Mannheim) according to the manufacturer's instructions. To detect the V J rearrangements in each of the EU12 subpopulations, the protocol of PCR amplification using a set of V and J primers was used as described. 26 
Ig gene sequencing and single-cell PCR assay
To determine HC and LC transcript sequences, cDNA of the test cells was synthesized for PCR amplification as previously described. 23 Pan-V H FR1 and C primers were used for amplification of the HC cDNAs, and the set V and J primers and PCR protocol for LC cDNA amplification were performed as above. The PCR products of HC or LC transcripts were isolated and subjected to the TA cloning reaction as described by the manufacturer (Invitrogen, Carlsbad, CA). Plasmids carrying HC or LC transcripts were purified from randomly selected Escherichia coli colonies for sequencing reactions. For analysis of singlecell V H usage, individual HC ϩ EU12 cells were deposited into tubes containing 20 L PCR buffer with 0.25 mg/mL proteinase K. Reactions were incubated at 50°C for 1 hour and used as templates in a single-cell PCR assay. In the first-round PCR reaction, a combination of V H 1,2,3-specific oligonucleotides was used as forward primer, and an oligonucleotide sequence common to J H 1,2,4,5 was used as the reverse primer. In the second round of a nested PCR, 5 L of the first PCR reaction product was used as the template, individual V H oligonucleotides were used as the forward primer, and the J H 1,4,5 oligonucleotide was used as the nested reverse primer. The primer sequences have been described 27 and the protocol included first-round V H gene amplification at 95°C for 5 minutes, 59°C for 4 minutes, and 72°C for 3 minutes (cycle 1); 95°C for 30 seconds, 59°C for 30 seconds, and 72°C for 80 seconds (cycles 2-36); then extension at 72°C for 5 minutes; and maintenance at 4°C. For second-round PCR, the protocol for amplification of the first round PCR product included 95°C for 3 minutes, 61°C for 1 minute, 72°C for 1 minute (cycle 1), 95°C for 1 minute, 61°C for 30 seconds, 72°C for 50 seconds (cycles 2-40), and extension at 72°C for 5 minutes, and then maintenance at 4°C. PCR products were separated by electrophoresis on a 1.5% agarose gel and purified for the sequencing reaction by using a gel extraction kit (Qiagen, Valencia, CA). Purified PCR products were sequenced directly using V H -specific primers. All sequences were analyzed with the DNAplot program (http://www.dnaplot.de/).
Results
Phenotypic and karyotypic characterization of the EU12 leukemic cell line
EU12 was unique among a panel of 11 ALL cell lines in that phenotypic analysis identified cells at multiple stages of B-lineage differentiation. All of the EU12 cells expressed the CD19, CD20, CD22, CD23, CD32, CD33, CD38, CD40, and HLA-DR antigens, but subpopulations of this cell line were found to be either positive or negative for CD34, CD10, and HC ( Figure 1 ). Differential immunofluorescence analysis indicated that the EU12 cell line is composed of 3 distinctive subpopulations: CD34 ϩ sHC Ϫ (R1), CD34 Ϫ sHC Ϫ (R2), and CD34 Ϫ sHC ϩ (R3). The latter subpopulation could be subdivided into sHC low SLC ϩ (R3A) and sHC high LC ϩ (R3B) subsets ( Figure 1 ). Cells in both the R3A and R3B subsets expressed cell surface SLCs, and the cells in the R3B subset also expressed LCs and ␦HCs. The HC low R3A cells thus bear pre-BCR, whereas the HC high R3B cells have pre-BCR and BCR. IL-7R, barely detectable on the R1 and R2 subpopulations, was present at higher levels on the R3A and R3B subsets.
To characterize further the developmental stages of the EU12 cell line, each subpopulation was purified for intracellular immunofluorescence analysis ( Figure 1 ). VpreB was found in permeabilized cells of all 3 subpopulations, whereas HC was observed only in R3 cells and rarely in R2 cells (Ͻ 1%). In contrast, TdT expression was evident in most R1 and R2 cells, but not in the R3 subpopulation. The composite data from this analysis indicate that the EU12 cell line contains cells of pro-B (R1 and R2), pre-B (R3A), and B-cell (R3B) phenotypes, although the B-cell subpopulation is unusual in its IL-7R expression and simultaneous expression of surrogate and conventional LCs.
The distinctive phenotype of EU12 cell line prompted a detailed cytogenetic analysis, and the results indicated the EU12 cell line is nearly tetraploid and has complex abnormalities involving chromosomes 2, 3, 4, 5, 6, 7, 11, 12, 17, and 21. Detailed description of its chromosome complement is as follows: 88, XXYY, ϩ2, del(2)(q13) ϫ 2, del(3)(q26.2),Ϫ4, der(4)t(2;4) (q13;q21), inv(5)(q15q33) ϫ 2, del(6)(q23) ϫ 2, t(7;21) (p13;q11) ϫ 2,Ϫ8,Ϫ9,Ϫ11, del(11)(p13),Ϫ12, add(12)(p13), ϩ13,Ϫ14,Ϫ14, ϩ16, del(17)(p11) ϫ 2, add(17)(p13), Ϫ18, ϩ20,Ϫ21, der(21)t(7;21)(p13;q11), ϩmar.
EU12 cells spontaneously undergo pro-B to B-cell differentiation
The representation of multiple stages of B-lineage differentiation among the EU12 cells suggested this cell line either is undergoing differentiation or represents a multiclonal mixture of cells. To discern between these possibilities, each subpopulation was purified by 2 rounds of FACS before reculture and phenotypic monitoring. Serial immunofluorescence analysis indicated that isolated cells of pro-B cell phenotype (CD34 ϩ HC Ϫ ) gave rise to cells of pre-B phenotype (CD34 ϩ HC low ) by day 12 and cells of B-cell phenotype (CD34 Ϫ HC high ) by 3 weeks in culture. Purified cells of the R2 subset (CD34 Ϫ HC Ϫ ) likewise gave rise to cells of pre-B and B-cell phenotypes, whereas the R3 subpopulation 
Differential gene expression profiles in the EU12 subpopulations
Cells representative of each definable stage in EU12 differentiation were purified by 2 rounds of FACS before RT-PCR analysis of their gene expression profile ( Figure 3 ). As anticipated from its protein expression profile (Figure 1) , the TdT lymphoid cell-specific gene was down-regulated in the R3A subset and extinguished in the R3B subset. Rag1 was found to follow a similar expression pattern, whereas Rag2 transcripts were expressed in all of the subpopulations, as were transcripts for the mb1, B29, 5, and VpreB B-lineage genes. In keeping with results of the immunofluorescence analysis (Figure 1) , IL-7R and C transcripts were not detected in the R1 pro-B cells, but were expressed in subpopulations representing later stages in differentiation. Interestingly, Bcl-2 transcription was noticeably down-regulated in the R3B B-cell subpopulation, possibly suggesting that the most mature EU12 cells are more susceptible to programmed cell death. These data support the conclusion that the EU12 cells undergo many of the changes in gene expression that characterize normal B-cell differentiation.
Analysis of Ig HC and LC gene configuration in the EU12 cells
Southern blot analysis was initially used to characterize the Ig gene rearrangement status at the different EU12 differentiation stages. Restriction enzyme-digested gDNA samples of each EU12 subpopulation, and of placenta as a germline control, were hybridized with J H , C , and C probes ( Figure 4 A-B ; data not shown). Germline J H -containing fragments were not detectable in the unfractionated EU12 cells; instead, 2 rearranged bands were observed, a dominant 6.2-kb band and a minor 12-kb band ( Figure 4A , lane 2). Of these, the R1 and R2 subpopulations contained only the 6.2-kb band ( Figure 4A, lanes 3 and 4) , whereas the HC ϩ R3 subpopulation contained both bands of similar intensity ( Figure 4A, lane 5) . These findings, together with a karyotypic analysis demonstrating 2 copies of chromosome 14 (data not shown), suggest that the least differentiated R1 cells of EU12 contain 2 very similar J H rearrangements, but are incapable of producing HCs because the rearrangements either are incomplete DJ H or nonproductive VDJ H . The occurrence of an additional rearrangement event on one HC allele in the R3 cells coincides with the expression of HC.
No J hybridizing bands were detected in a DNA blot analysis of the LC locus (data not shown) in accordance with the absence of LC transcripts in EU12 cells (Figure 3 ). These findings suggest that the EU12 clone has deleted the LC locus, although chromosome 2 appeared intact at the level of resolution provided by karyotypic analysis. When EcoRI-digested DNA samples from each subpopulation were hybridized with the C probe, a rearranged J C segment was evident among the 7 J C gene pairs in the R3 subpopulation ( Figure 4B ). The finding demonstrates V 3J C gene rearrangement in the HC ϩ R3 subpopulation, but not in the earlier fractions, and is consistent with the proposed developmental sequence R13R23R3. The cDNA sequence analysis ( Figure 5 ) indicates that multiple rearrangements using the same J C gene segments have occurred during the in vitro differentiation of the EU12 cells.
V H and V L gene usage in EU12 cells
To examine the extent of V(D)J recombinatorial diversification in the EU12 cells, the HC ϩ R3 subpopulation of cells was purified and RNA extracted for cDNA synthesis and PCR amplification of HC transcripts using PanV H FR3 and C primers. The resultant HC PCR products were cloned and the analysis of sequences obtained from 17 randomly selected clones identified the same DXPЈ1/J H 4 gene segment rearrangement with no nucleotide addition in this D-J H joint region. This analysis also demonstrated the use of multiple V H gene segments by EU12 cells in that the V H 3-7 gene segment was found in 12 of the 17 cDNA clones, V H 1-8 in 3 To avoid possible transcriptional bias in this analysis of V H gene usage, we performed a single-cell genomic PCR assay of sorted HC ϩ EU12 cells. The sequences derived from a panel of single-cell V H gene PCR products recaptured the 2 major V H 3-7 gene rearrangements observed in the earlier analysis of HC cDNA clones ( Figure 5B ). In addition, we identified a V H 2-5 rearrangement with the same DXPЈ1/J H 4 sequence observed in the cDNA clones; however, this rearrangement was nonfunctional because of a reading frame shift. The resulting transcript would be targeted for destruction by nonsense-mediated mRNA decay, 28 thereby explaining why V H 2-5 gene segment usage was not observed in the cDNA analysis. Consistent with the cDNA sequence analysis, 2 patterns of nucleotide additions were observed in the joint region between V H 3-7 and DXPЈ1/J H 4. The dominant joint region sequence featured a CCCC nucleotide addition, presumably added during the V H 3DJ H recombination process. The other additions were longer and contained a consensus CACA sequence that was also found at the 3Ј end of V H 2-5 gene segment.
With this information in hand, genomic PCR assays were performed to determine more precisely when the V(D)J rearrangements occurred during the EU12 cell differentiation process. Primers able to discriminate between DJ H and V H DJ H rearrangements were used in this analysis ( Figure 6A ). In a control experiment, the internal DXPЈ1 primer was used in conjunction with a downstream J H 6 primer, and genomic PCR products of the expected size were detected in each EU12 subpopulation after hybridization with a J H 5-specific probe ( Figure 6B ). This result was as expected because the primer combination amplifies both VDJ H and DJ H rearrangements. To assay specifically for DJ H rearrangements, a primer based on the sequence upstream of the germline DXPЈ1 gene segment (DXPЈ1 ext) was used in conjunction with internal J H 5 primers and the PCR products were detected by a specific internal DXPЈ1 probe. The EU12 cells in each purified subpopulation were found to contain a DJ H segment rearrangement, albeit at apparently reduced levels in the R3 pre-B/B cell subpopulation ( Figure 6C ). Using PanV H FR3 and J H 5 primers in an assay that allows definition of the presence or absence of VDJ H rearrangements but does not identify unique rearrangements, VDJ H gene rearrangement was detected in the R2 subpopulation, and to a much greater extent in the R3 subpopulation ( Figure 6D ). The nonfunctional V H 2-5 DXPЈ1/J H 4 rearrangement was not detected in this assay because the PanV H FR3 primer does not recognize the V H 2-5 gene segment. However, using a V H 2-specific primer, a genomic PCR product was detectable in the R1, R2, and R3 subpopulations (not shown).
In an analysis of the V usage, cDNA derived from the HC ϩ R3 cells served as the template for PCR amplification of V -J and VL-C (C) transcripts using primer combinations described in "Materials and methods." (B) Single HC ϩ EU12 cells were sorted into PCR tubes with lysis buffer, and used for 2-round genomic PCR as described in "Materials and methods." PCR products were purified and directly sequenced with specific VH primers.
transcripts using a panel of V and J primers. 26 Analysis of the sequences obtained from 8 randomly selected cDNA clones indicated the use of at least 2 V gene segments each of which was recombined with the same J 2C 2 gene segment ( Figure 5C ), data consistent with the observation of a single rearranged band on the Southern blots ( Figure 4B ). V 3-19 gene segment usage appeared dominant, being seen in 6 of 8 clones, whereas V 3-10 was used in the other 2 clones. Variations in the N nucleotide additions were also observed in LC transcripts with both V gene segments, indicating the occurrence of multiple V 3J 2C 2 rearrangements in the R3 subpopulation. In a genomic PCR assay to detect V 3J rearrangements, VJ rearrangements were detectable in R2 cells and to a much greater extent in the R3 cells ( Figure 6E) .
The prevalent usage of a limited number of V H gene segments and the occurrence of the same DJ H rearrangements over a 2-year interval for EU12 subclones suggested a predisposition of the individual EU12 pro-B cells to undergo particular V H 3DJ H rearrangements. Alternatively, each pro-B cell might give rise to progeny that would use one of a limited number of V H gene segments for rearrangement. To determine whether individual EU12 pro-B cells with the DXPЈ1/J H 4 rearrangement could generate intraclonal V H gene diversity, DNA samples of 4 EU12 subclones were isolated for genomic PCR analysis of V H gene utilization. Each of the subclones was derived from a single cell with the pro-B phenotype (R1 in Figure 2B ) and the subclones were selected on the basis of their phenotypic profiles after 10 weeks in culture ( Figure 7A ). Whereas HC ϩ cells were not seen in subclone 1, subclone 2 progeny reached the pre-B cell stage, and subclones 3 and 4 contained both pre-B and B-cell subpopulations. In an assay of V(D)J rearrangements using the V H -specific primers used for the single-cell PCR analysis described, all 4 subclones were found to undergo the V H 2-DJ H rearrangement ( Figure 7B ). Subclone 2 also exhibited a V H 3-DJ H rearrangement, subclone 3 had a V H 1-DJ H rearrangement, and subclone 4 was the most diverse, manifesting all 3 V H gene segment rearrangements ( Figure  7B ). These results, which confirm the single-cell PCR sequence analysis, indicate that the progeny of individual EU12 pro-B cells can undergo productive VDJ rearrangements involving more than one V H gene segment. These findings formally establish that individual EU12 pro-B cells can give rise to intraclonal V H diversity during B-cell generation.
Discussion
These studies define a clonal model of human B-cell development in which the pro-B cell subpopulation, as well as the individual pro-B cells, can spontaneously generate pre-B and B-cell progeny. The B lineage-specific gene expression profiles for each of these subpopulations resemble those observed during normal B-cell differentiation. These characteristics define the EU12 cell line as a novel model that recapitulates many of the central features of the human B-cell differentiation pathway.
Mouse pre-B cell hybridomas, 2 Abelson murine leukemia virus (AMuLV)-transformed cell lines, 29 human Epstein-Barr virustransformed B-cell precursors, 24 and ALL-derived tumor cell lines 30 have been used in previous studies to gain insight into the sequential nature of Ig H and L chain gene rearrangements during B-lineage differentiation. Although most of these cell lines represent clonal populations frozen in a particular stage of B-lineage differentiation, the AMuLV-transformed cell line 300-19 was found to undergo pro-B to B-cell differentiation. 29 However, this proved to be an unstable phenotype because the AMuLV-transformed cell lines extinguish their Rag1/2 expression with prolonged cultivation. 31 In humans, the search for an in vitro culture system or cell lines that recapitulate early B-lineage cell differentiation and self-renewal for cellular and molecular studies has been an ongoing challenge. 32 One leukemic cell line, BLIN-1, was shown to undergo pre-B to B-cell differentiation at low frequency, 30 and a more recently described cell line, BLIN-3, can progress from the pro-B to the pre-B cell stage in a stromal cell-dependent manner. 33 The EU12 cell line is unique in maintaining 4 distinguishable subpopulations, CD34 ϩ sHC Ϫ (R1), CD34 Ϫ sHC Ϫ (R2), CD34 Ϫ sHC low (R3A), and CD34 Ϫ sHC high s␦HC ϩ LC ϩ (R3B), that recapitulate sequential stages in the normal B-cell differentiation pathway. Analysis of cell surface and intracellular SLC, TdT, and HC expression indicates the pro-B cell nature of the R1 cells, while suggesting that the R2 cells represent a transitional pro-B to pre-B cell stage. The R3A cells express pre-BCR, whereas R3B cells express BCR indicating their B-cell status.
The sorted R2 subpopulation can give rise to occasional CD34 low HC Ϫ cells, raising the possibility that this subset may contain rare precursors at an earlier stage of development than R1 cells. Although we cannot exclude the possibility of very rare pre-R1 cells, it seems unlikely that the R2 subset contains earlier progenitors. First, cells in all of the EU12 subpopulations express high levels of the B-lineage marker CD19, indicating that all R2 cells are B lineage-committed cells. Second, although sorted R2 cells can give rise to some CD34 low HC Ϫ cells, these cells never express levels of CD34 antigen as high as those seen on the original R1 subpopulation, possibly suggesting they are in a transition state between the R1 and R2 subsets. The CD34 Ϫ HC Ϫ cells represent a very minor proportion of B-lineage cells in normal bone marrow, yet R2 cells of this phenotype comprise a significant proportion among the EU12 cells. The explanation for this may lie in the fact that during normal B-lineage cell development, only a minor portion of the CD34 ϩ CD19 ϩ HC Ϫ pro-B cells undergo V3DJ H gene rearrangement to produce HC and become pre-B cells. Those that fail to make productive VDJ rearrangements may undergo apoptosis in vivo and therefore are eliminated. Although the R2 subset represents a pro-B to pre-B transitional stage because that is in the process of undergoing V3DJ H rearrangement, most of these cells fail to produce HC. Nevertheless, the cells may not undergo immediate apoptosis due to the transformed characteristics and in vitro location of the EU12 cells, thereby leading to an exaggerated representation of this differentiation stage.
Another notable departure from the normal B-cell differentiation scheme was observed for the EU12 cell line. SLC expression is normally down-regulated to extinguish pre-BCR expression at the late pre-B cell stage. 11 As a consequence, the receptorless pre-B cells exit the cell cycle and up-regulate their Rag1 and Rag2 expression to undergo V-J L gene segment rearrangements. EU12 B cells instead were found to coexpress pre-BCR and BCR, a feature noted previously for other "transitional pre-B/B" cell lines, [34] [35] [36] thus questioning why these transitional B cells fail to extinguish SLC gene expression and the possible role this failure may have in the leukemogenesis process. A complex locus control region, including the promoters and 5Ј enhancer for the VpreB and 5 genes, has been identified in mice. [37] [38] [39] [40] The promoter regions of both genes contain binding sites for Ikaros, EBF, E2A, and PAX5, [41] [42] [43] and these transcription factors are expressed throughout the pre-B cell differentiation process. Ikaros-mediated transcriptional silencing [44] [45] [46] may provide a mechanism for SLC gene down-regulation in normal late-stage pre-B cells. On the other hand, dominantnegative Ikaros isoforms, including Ikaros 6, have been found to be preferentially expressed in ALLs and could interfere with the usual transcriptional silencing of SLC genes. 47, 48 The clonal EU12 cell line may provide a suitable model to test this hypothesis.
B-cell leukemias and lymphomas are considered clonal diseases derived from a single transformed precursor, based on the analysis of their karyotypes, glucose-6-phosphate dehydrogenase (G6PD) isoenzymes, and BCR idiotypes. [49] [50] [51] However, 15% to 45% of ALLs of B lineage represent oligoclonal malignancies according to the diversity of their HC gene expression. [52] [53] [54] [55] [56] [57] Analysis of these patients has indicated that the leukemic population may diversify by generating multiple IgH gene rearrangements during the process of tumor progression. [55] [56] [57] Sequence analysis of the IgH genes has suggested that both V H 3DJ H and V H 3VDJ H recombinational events can occur during the clonal evolution of B cell leukemias. 55 All of the cells in the clonal EU12 cell line, established from a childhood B-lineage ALL, apparently contain the same DXPЈ1/J H 4 rearrangement with no N nucleotide addition in the DJ H join. This suggests that the formative transformational event may have occurred during fetal life in a pro-B cell that had undergone D3J H rearrangement. 58 Interestingly, overrepresentation of the DXPЈ1 and J H 4 gene segments has been observed in other ALL samples. 57, 59 Sequence analysis of the V H gene rearrangements in the EU12 B cells indicated the use of 4 gene segments, V H 2-5, V H 3-7, V H 3-11, and V H 1-8, which are clustered in the D H proximal region of the HC locus. Preferential usage of the D H proximal V H gene segments has been noted previously in mice 60 and in human ALL. 61 The nontemplated nucleotide additions observed at the site of V-DJ joining include a dominant CCCC tetranucleotide, and other unusually long sequences that contain a consensus CACA sequence identical to the 3Ј end of the V H 2-5 gene segment, located just 3Ј to the conserved internal cryptic RSS heptamer (TACTGTG). These results suggest that the onset of HC expression in EU12 B cells could result from a V H 3DXPЈ1/J H 4 recombination and by V H 3nonfunctional V H 2-5-DXPЈ1/J H 4 replacement events. The occurrence of V H gene replacement was initially suggested by studies of murine cell lines as a mechanism that could generate a functional HC gene from a nonproductive VDJ H rearrangement. 62, 63 The possible occurrence of V H gene replacement has been suggested by analysis of the V H repertoire of human B-lineage ALL 55, 64 and in a transgenic mouse carrying a VDJ H rearrangement targeted to the endogenous IgH locus. 65 Confirmation of ongoing V H gene replacement as a mechanism to generate the unique EU12 CDR3 regions would make this cell line a valuable model to define the mechanism of the V H gene replacement reaction.
The discovery of sequential rearrangement and expression of Ig HC and LC genes in the immediate precursors of mammalian B cells led to the idea that intraclonal V(D)J recombinatorial diversification might occur during B-cell genesis. 19 The present studies provide direct evidence for the validity of the principle of intraclonal V(D)J diversification, in that individual EU12 pro-B cells marked with a DXPЈ1/J H 4 gene segment give rise to a diverse repertoire during their progression from the pro-B to B-cell stage. Our analysis of the EU12 cell line model also suggests that V H 3DJ H recombination and V H 3VDJ H replacement events can occur contemporaneously in early B-lineage cells to generate intraclonal V(D)J recombinatorial diversity independent of the bone marrow microenvironment. The EU12 cell line thus provides a useful model for analysis of the progression of human B-cell development.
